Abstract
Introduction: hematuria, defined as the presence of blood in urine, poses a therapeutic challenge when refractory to conventional treatments. Its prevalence ranges from 2.5% to 20% in adults, with 80% of cases being of urological origin. Initial management strategies include hydration, three-way Foley catheter insertion, and clot evacuation. However, in refractory cases, innovative therapeutic alternatives such as aluminum salts are warranted. Objective: to describe the outcomes of continuous bladder irrigation with aluminum sulfate solution for the treatment of hematuria through a case series. Methods: this was an observational, descriptive, and retrospective case series study conducted in a quaternary care hospital in Barranquilla, Colombia, during 2024. Ten male patients (median age: 71 years) hospitalized due to spontaneous hematuria were included. Following the failure of conservative management, continuous bladder irrigation with 1% aluminum sulfate solution (30 g in 3000 mL of sterile water) was administered at a rate of 200 mL/h. Results: complete resolution of hematuria was achieved in 100% of cases within 48–72 hours of treatment. The most frequent comorbidities were prostatic disease (90%), arterial hypertension (60%), and chronic kidney disease (60%), with bacterial colonization detected in 60% of cases. Cystoscopic findings included prostatic abnormalities (90%), bladder inflammation (20%), and lithiasis (10%), with retained clots observed in all patients. Conclusions: A 1% aluminum sulfate solution appears to be a safe and effective therapeutic option for the management of refractory hematuria. Nevertheless, prospective clinical trials are required to establish the optimal treatment protocol.

This publication has 13 references indexed in Scilit: